Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells
M. Murphy et al., Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells, J BIOL CHEM, 274(9), 1999, pp. 5830-5834
Accumulation of mesangial matrix is a pivotal event in the pathophysiology
of diabetic nephropathy. The molecular triggers for matrix production are s
till being defined. Here, suppression subtractive hybridization identified
15 genes differentially induced when primary human mesangial cells are expo
sed to high glucose (30 mM versus 5 mM) in vitro. These genes included (a)
known regulators of mesangial cell activation in diabetic nephropathy (fibr
onectin, caldesmon, thrombospondin, and plasminogen activator inhibitor-1),
(b) novel genes, and (c) known genes whose induction by high glucose has n
ot been reported. Prominent among the latter were genes encoding cytoskelet
on-associated proteins and connective tissue growth factor (CTGF), a modula
tor of fibroblast matrix production. In parallel experiments, elevated CTGF
mRNA levels were demonstrated in glomeruli of rats with streptozotocin-ind
uced diabetic nephropathy. Mannitol provoked less mesangial cell CTGF expre
ssion in vitro than high glucose, excluding hyperosmolality as the key stim
ulus. The addition of recombinant CTGF to cultured mesangial cells enhanced
expression of extracellular matrix proteins. High glucose stimulated expre
ssion of transforming growth factor beta 1 (TGF-beta 1), and addition of TG
F-beta 1 to mesangial cells triggered CTGF expression. CTGF expression indu
ced by high glucose was partially suppressed by anti-TGF-pl antibody and by
the protein kinase C inhibitor GF 109203X. Together, these data suggest th
at 1) high glucose stimulates mesangial CTGF expression by TGF beta 1-depen
dent and protein kinase C dependent pathways, and 2) CTGF may be a mediator
of TGF beta 1-driven matrix production within a diabetic milieu.